This research assesses episodic memory dysfunction's impact on Alzheimer's disease biomarkers and cognition, indicating significant implications for treatment strategies.
Key Points
The study aims to understand how episodic memory network dysfunction relates to Alzheimer’s disease progression and cognitive decline.
Analyzed longitudinal fMRI data from over 1000 individuals in the DZNE DELCODE study.
Investigated activation and deactivation patterns of the episodic memory network.
Conducted voxel-wise analyses to assess neurodegeneration and cognitive decline.
Evaluated disease progression scores using a disease progression model.
Identified widespread loss of activation and deactivation within the episodic memory network.
Noted nonlinear trajectories for loss of deactivation associated with amyloid and tau positivity.
Observed that the deactivation loss trajectory visually preceded cognitive decline.
Found that deactivation's relationship to cognitive decline was partially independent of neurodegeneration.